CAS: 59831-65-1 - Halopemide
Formula:C21H22ClFN4O2
InChI:InChI=1/C21H22ClFN4O2/c22-15-3-6-19-18(13-15)25-21(29)27(19)17-7-10-26(11-8-17)12-9-24-20(28)14-1-4-16(23)5-2-14/h1-6,13,17H,7-12H2,(H,24,28)(H,25,29)
- Synonyms:
- 59831-65-1
- N-[2-[4-(5-Chloro-2,3-dihydro-2-oxo-1H-benzimidazol-1-yl)-1-piperidinyl]ethyl]-4-fluorobenzamide
- N-{2-[4-(5-Chloro-2-oxo-2,3-dihydro-1H-benzimidazol-1-yl)piperidin-1-yl]ethyl}-4-fluorobenzamide
Halopemide
Controlled ProductCAS:59831-65-1
Applications Halopemide acts as a small molecule inhibitor for phospholipase D (PLD), an important phosphlipid …
Formula:
C21H22ClFN4O2
Color and Shape:
Neat
Molecular weight:
416.876
Ref: TR-H103695
100mg | 2,172.00 € |
Estimated delivery in United States, on Tuesday 21 Jan 2025
N-[2-[4-(5-Chloro-2,3-dihydro-2-oxo-1H-benzimidazol-1-yl)piperidino]ethyl]-4-fluorobenzamide
CAS:59831-65-1
N-[2-[4-(5-Chloro-2,3-dihydro-2-oxo-1H-benzimidazol-1-yl)piperidino]ethyl]-4-fluorobenzamide (NFA) is a novel benzodiazepine receptor inverse agonist that has been shown to be …
Formula:
C21H22ClFN4O2
Purity:
Min. 95%
Molecular weight:
416.88 g/mol
Ref: 3D-FC145515
1mg | To inquire | ||
5mg | To inquire | ||
10mg | To inquire |
Estimated delivery in United States, on Tuesday 21 Jan 2025
Halopemide
CAS:59831-65-1
Halopemide is a potent inhibitor of PLD (IC50 = 220 and 310 nM for human …
Formula:
C21H22ClFN4O2
Purity:
96.29%
Color and Shape:
Solid
Molecular weight:
416.88
Ref: TM-T15461
1mg | 34.00 € | ||
5mg | 82.00 € | ||
10mg | 122.00 € | ||
25mg | 236.00 € | ||
50mg | 351.00 € | ||
100mg | 511.00 € | ||
1mL*10mM (DMSO) | 91.00 € |
Estimated delivery in United States, on Monday 27 Jan 2025